M. Zhu

发表

Successful application of PD-1 knockdown CLL-1 CAR-T therapy in two AML patients with post-transplant relapse and failure of anti-CD38 CAR-T cell treatment.

Hong-jie Shen, Dan-dan Liu, Xiaowen Tang, 2022, American journal of cancer research.

[Clinical implication of minimal residual disease monitoring by 10-color flow cytometry in multiple myeloma].

C. Fu, J. Shang, M. Zhu, 2019, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.

Integrative genomic and transcriptomic profiling reveals distinct molecular subsets in adult mixed phenotype acute leukemia

Hong Liu, J. Cen, Hong-jie Shen, 2022, American journal of hematology.

Haploidentical CD7 CAR T-cells induced remission in a patient with TP53 mutated relapsed and refractory early T-cell precursor lymphoblastic leukemia/lymphoma

Lin Yang, Huimin Meng, H. Dai, 2022, Biomarker Research.

CD38-directed CAR-T cell therapy: a novel immunotherapy strategy for relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation

Depei Wu, Xiaowen Tang, Tianhui Liu, 2020, Journal of Hematology & Oncology.

Case report: CD38-directed CAR-T cell therapy: A novel immunotherapy targeting CD38- positive blasts overcomes TKI and chemotherapy resistance of myeloid chronic myeloid leukemia in blastic phase

Lei Yu, L. Yao, J. Cen, 2022, Frontiers in Immunology.

Molecular genetics and management of world health organization defined atypical chronic myeloid leukemia

J. Cen, Dan-dan Liu, Depei Wu, 2023, Annals of Hematology.

CD38-directed CAR-T cell therapy: a novel immunotherapy strategy for relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation

Depei Wu, Xiaowen Tang, Tianhui Liu, 2021, Journal of Hematology & Oncology.

Venetoclax with Decitabine as Frontline Treatment for Younger Adults with Newly Diagnosed ELN Adverse-Risk AML.

L. Yao, J. Cen, Dan-dan Liu, 2023, Blood.